Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
about
The effects of repetitive vibration on sensorineural function: biomarkers of sensorineural injury in an animal model of metabolic syndromeDiet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic ratsEnriching the diet with menhaden oil improves peripheral neuropathy in streptozotocin-induced type 1 diabetic rats.Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complicationsEffect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.Microvascular responsiveness in obesity: implications for therapeutic intervention.Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat.Partial replacement with menhaden oil improves peripheral neuropathy in high-fat-fed low-dose streptozotocin type 2 diabetic ratEarly loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.Obesity and statins are both independent predictors of enhanced coronary arteriolar dilation in patients undergoing heart surgeryIncreased tissue angiotensin-converting enzyme activity impairs bradykinin-induced dilation of coronary arterioles in obesityNa+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats.An overview of the extra-lipid effects of rosuvastatin.Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688.Gene-nutrition and gene-physical activity interactions in the etiology of obesity. Introduction.Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic ratsPathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts.Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.Pleiotropic effects of statins: new therapeutic targets in drug design.Proteomic analysis reveals downregulation of housekeeping proteins in the diabetic vascular proteome.Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signalingThe effect of perindopril on postural instability in older people with a history of falls-a randomised controlled trial.Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.Glyoxalase 1 and glyoxalase 2 activities in blood and neuronal tissue samples from experimental animal models of obesity and type 2 diabetes mellitus.
P2860
Q23918126-45928033-E61D-4EAF-8100-4EC544C39BCCQ33884283-74D3E444-0407-4C38-B10B-522B9AA42F4AQ34106165-F91D2C04-3824-44E9-A530-74B6A190C4F9Q34469283-608F5CF7-6D3D-472C-BB24-538D9B42EEEAQ35034925-7941110D-B84A-41CE-BC26-8EE4AEE03E68Q35125198-9548FBE8-8A54-4B8E-AACC-F23286205A92Q35256354-794B87A6-6966-4DEF-9DF9-844C70946FC6Q35713274-495A265C-EA68-4104-83BD-93DC960A6752Q35859728-2EC4A8A5-02D2-46BC-9C7A-DC92FB143501Q35921421-EED177EA-1E2C-454C-98CA-A06FCBC7F1A0Q36228773-934DEE2F-9F39-4D2A-B859-4F567783DD7BQ36453435-2A3D8479-1FDB-4918-9F26-5BE8317CB008Q36858651-EBD24B82-58E0-476F-A92E-94BFB4D95FFCQ36965013-CF23BD2E-5EC8-4DCC-B7F0-998B9CBA094DQ37093605-6DA9B056-434D-4EF6-B608-C638F80EF627Q37156139-4FB0F46E-10D5-4CCF-9B15-538479CBC877Q37226410-DB0F0E2A-4E83-4C65-8E2D-DA045C34C23DQ37244313-A2F7786E-7DA6-4B17-B04F-8C5F071442EBQ37605348-8B094CF7-C9C2-4D68-AEA9-67A5B1034944Q37615861-C096B08C-3A29-499C-9C5C-E102912EBA16Q38036887-2A818906-E0A6-4A4E-B5D4-6F16C8FCD4B8Q38671591-E137C526-B583-4624-8C8F-E8D0319F9385Q38825843-3EF2979B-88FA-4B72-840F-69A9E4993C1AQ39233717-FBBECD70-AA95-455B-BC36-F6E40EF0E363Q39948284-79E8BCD0-B1CE-4B91-928F-530A6B61F3D4Q47618064-32219C5D-CA29-4CE0-8132-0A6618E21188Q47845721-7C46067E-8C28-43C2-AEBC-7F6B2D29E7D0Q48408862-F4C0C1CE-E6BD-47FA-9590-02A818F103F5
P2860
Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@en
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@nl
type
label
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@en
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@nl
prefLabel
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@en
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@nl
P2093
P2860
P356
P1433
P1476
Attenuation of vascular/neural ...... ith enalapril or rosuvastatin.
@en
P2093
Christine L Oltman
Donald D Lund
Eric P Davidson
Lawrence J Coppey
Mark A Yorek
Travis L Kleinschmidt
P2860
P356
10.1038/OBY.2007.19
P577
2008-01-01T00:00:00Z